(Q44996702)
Statements
1 reference
A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer (English)
1 reference
Nicholas J Vogelzang
1 reference
Matthew D Galsky
1 reference
Paul Conkling
1 reference
Eyas Raddad
1 reference
John Polzer
1 reference
Stephanie Roberson
1 reference
John R Stille
1 reference
Mansoor Saleh
1 reference
Donald Thornton
1 reference
11 April 2014
1 reference
1 reference
20
1 reference
13
1 reference
3581-3588
1 reference
Identifiers
1 reference
1 reference